May 30, 2013
Eli Lilly and Company (NYSE: LLY) has issued the following statement from Senior Vice President Bart Peterson regarding today's announcement introducing the Indiana Biosciences Research Institute:
"The Indiana Biosciences Research Institute will change the bio-landscape of our region.
's life sciences companies spend billions of dollars in research and development each year to advance health care innovations for improved human health. The Institute will help us nurture our partnerships across the country and develop more intellectual capital here in
-- allowing us to keep more research dollars in the state, attract more federal research funds, and draw top scientific minds to feed our research pipeline and local economies.
has been a life sciences leader. We have roughly 2,000 companies, big and small, that focus on life sciences in our state. Our biopharmaceutical companies, agricultural science companies, device and diagnostic companies, and world-class universities have collectively pushed
to the front of the line as a life sciences hub. Moving forward, the institute will help us tear down silos and bring our organizations together – benefitting patients who desperately need better solutions for emerging diseases and other difficult health care challenges.
"This institute is unique because Lilly and other private sector companies are partnering with state government and three major universities to support its creation – and it will make all Hoosier bioscience companies, including Lilly, even stronger. An impressive roster of collaborators, an environment that attracts national and international talent, and an infrastructure that allows us to build a deeper library of intellectual property will separate
from other states attempting to replicate our success.
"A decade ago, BioCrossroads helped
become a more attractive place for life sciences companies to do business. Today, we collectively take the next step with the Indiana Biosciences Research Institute."
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in
, Lilly provides answers – through medicines and information ─ for some of the world's most urgent medical needs. Additional information about Lilly is available at
(317)432-5195 (m); (317)277-4021 (o) -
SOURCE Eli Lilly and Company